Periodontal immune responses of human lymphocytes in Actinobacillus actinomycetemcomitans-inoculated NOD/SCID mice engrafted with peripheral blood leukocytes of periodontitis patients

Journal of Periodontal Research

Volumn 34, Issue 1, 1999, Pages 54-61

  Teng, Yen Tung Andy ^a   Nguyen, H ^b   Hassanloo, A ^b   Ellen, R P ^b   Hozumi, N ^c   Gorczynski, R M ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Actinobacillus actinomytemcomitans; Adult periodontitis; Localized juvenile periodontitis; NOD SCID mice; Periodontal immunity

Indexed keywords

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ANIMAL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; LEUKOCYTE; LEUKOCYTE TRANSFUSION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MACROPHAGE; MICROBIOLOGY; MONOCYTE; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; OSTEOLYSIS; PERIODONTAL DISEASE; PERIODONTITIS; PERIODONTIUM; T LYMPHOCYTE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ALVEOLAR BONE LOSS; ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEUKOCYTE TRANSFUSION; LEUKOCYTES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED NOD; MICE, SCID; MONOCYTES; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL POCKET; PERIODONTITIS; PERIODONTITIS, JUVENILE; PERIODONTIUM; T-LYMPHOCYTES;

EID: 0032603386     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1999.tb02222.x     Document Type: Article

References (43)

1. Clark WB, Loe H. Mechanisms of initiation and progression of periodontal disease. Periodontol 2000 1993;2:72-82.
2. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985;12:1-20.
3. Zambon JJ, Umemoto T, De Nardin E, Nakazawa F, Christersson LA, Genco RJ. Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv Dent Res 1988;2:269-274.
4. Dzink JL, Tanner ACR, Haffajee AD, Socransky SS. Gram negative species associated with active destructive periodontal lesions. J Clin Periodontol 1985;12:648-659.
5. McArthur WP, Clark WB. Specific antibodies and their potential role in periodontal diseases. J Periodontol 1993;64:807-818.
6. Ebersole JL, Taubman MA. The protective nature of host responses in periodontal diseases. Periodontol 2000 1994;5:112-141.
7. Zambon JJ. Periodontal diseases: microbial factors. Ann Periodontol 1996;1:879-925.
8. Fives-Tayler P, Meyer D. Mintz K. Virulence factors of the periodontopathogen Actinobacillus actinomycetemcomitans. J Periodontol 1996;67:291-297.
9. Meyer DH, Fives-Tayor PM. Characterization of adherence of Actinobacillus actinomycetemcomitans to epithelial cells. Infect Immun 1994;62:928-935.
10. Brown LJ, Oliver RC, Loe H. Evaluating periodontal status of US employed adults. J Am Dent Assoc 1990;121:226-232.
11. Klausen B. Microbiological and immunological aspects of experimental periodontal disease in rats: a review article. J Periodontol 1991;62:59-73.
12. Taubman HA, Yoshie H, Wetherell JR Jr, Ebersole JL, Smith DJ. Immune response and periodontal bone loss in germfree rats immunized and infected with Actinobacillus actinomycetemcomitans. J Periodontol Res 1983;18:393-401.
13. Chen PB, Davern LB, Neiders ME, Reynold HS, Zambon JJ. Analysis of in vitro lymphoproliferative responses and antibody formation following subcutaneous injection of Actinobacillus actinomycetemcomitans and Wolinella recta in a murine model. Oral Microbiol Immunol 1991;6:12-16.
14. Wray D, Graeme L. Periodontal bone loss in mice induced by different periodontopathic organisms. Archs Oral Biol 1992;37:435-438.
15. Gilbert A, Wray D, Charon J. Immune response during experimental periodontitis in mice. J Fr Parodont 1990;9:175-178.
16. Kusumoto Y, Ogawa T, Hamada S. Generation of specific antibody-secreting cells in salivary glands of Balb/c mice following parenteral or oral immunization with Porphyromonas gingivalis fimbriae. Archs Oral Biol 1993;38:361-367.
17. Baker PJ, Todd Evans R, Roopenian DC. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Archs Oral Biol 1994;39:1035-1040.
18. Shenker BJ, Wannberg S, Vitale L, Kieba I, Lally ET. Reconstitution of severe combined immunodeficient mice with lymphocytes from patients with localized juvenile periodontitis. J Periodont Res 1993;28:487-490.
19. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988;335:256-259.
20. Shpitz B, Chambers CA, Singhal AB, et al. High level functional engraftment of SCID mice with human PBLs following pretreatment with radiation and anti-asialo GM1. J Immunol Methods 1994;169:1-10.
21. Sandhu J, Shpitz B, Gallinger S, Hozumi N. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J Immunol 1994;152:3808-3813.
22. Hozumi N, Gorczynski RM, Peters W, Sandhu JS. A SCID mouse model for human immune response and disease. Res Immunol 1994;145:370-379.
23. Teng Y-T, Ellen R, Nguyen H-P, Freeman E, Gorczynski R, Hozumi N. A SCID mouse model for studying human periodontal diseases. J Dent Res 1995;74 (special issue):57 (Abstr 363).
24. Teng Y-T, Nguyen H-P, Ellen R, Freeman E, Hozumi N, Gorczynski RM. Using NOD/SCID-HuPBL mouse model to study periodontal diseases. J Dent Res 1996;75 (special issue):350 (Abstr 2660).
25. Hassamloo A, Ellen R, Hozumi N, Teng Y-T. Periodontal immune profiles in Actinobacillus actinomycetemcomitans: Aa-inoculated NOD/SCID-HuPBL mice. J Dent Res 1998;77 (special issue): 158 (Abstr 419).
26. Choi J, Schifferle RE, Yoshimura F, Kim BW. Capsular polysaccharide-fimbrial protein conjugate vaccine protects against Porphyromonas gingivalis infection in SCID mice reconstituted with human peripheral blood lymphocytes. Infect Immun 1998;66:391-393.
27. Ranney RR. Classification of periodontal diseases. Periodontol 2000 1993;2:13-15.
28. Chen PB, Davern LB, Katz J, Eldridge JH, Michalek SM. Host responses induced by co-infection with Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans in a murine model. Oral Microbiol Immunol 1996;11:274-281.
29. Sato Y, Mukai K, Watanabe S, Goto M, Shimosato Y. The AMeX method a simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Am J Pathol 1986;125:431-435.
30. Coligan JE, Hruisbeek AM, Margulies DM, Shevach EM, Strober W. Current protocols in immunology. Wiley Inter-Science 1994;vol 1, chapter 7: 7.1.2; 7.2.1-7.2.3; 7.3.1-7.3.4, 7.5.1-7.5.3, 7.6.1.
31. Ochiai K, Kurita T, Nishimura K, Ikeda T. Immunoadjuvant effects of periodontitis-associated bacteria. J Periodont Res 1989;24:322-328.
32. Teng Y-T, Iwasaki S, Williams D, Gorczynski RM, Hozumi N. Evidence for Th2 cell-mediated suppression of antibody responses in transgenic, beef insulin tolerant mice. Eur J Immunol 1995;25:2522-2527.
33. Teng Y-T, Williams D, Hozumi N, Gorczynski RM. Multiple levels of regulation for self tolerance in beef insulin transgenic mice. Cell Immunol 1996;173:183-191.
34. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981;126:1614-1619.
35. Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L. Phenotype and function of human hematopoitic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 1996;88:3731-3740.
36. Hesselton RM, Greiner DL, Mordes JP, Rajan TV, Sullivan JL, Shultz LD. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type I infection in NOD/LtSz-scid/scid mice. J Infect Dis 1995;172:974-982.
37. Greiner DL, Shultz LD, Yates J, et al. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B.-17-scid/scid mice. Am J Pathol 1995;146:888-902.
38. Hoffmann-Fezer G, Gall C, Zengerle U, Kranz B, Thierfelder S. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood 1993;81:3440-3448.
39. Larochelle A, Vormoor J, Hanenberg H, et al. Identification of primitive human hematopoitic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat Med 1996;2:1329-1337.
40. + T cells repertoire in hu-PBL-SCID chimeras. J Exp Med 1994;180:1817-1827.
41. Tary-Lehmann M, Saxon A, Lehmann PV. The human immune system in hu-PBL-SCID mice. Immunol Today 1995;16:529-533.
42. Senpuku H, Iizima T, Koga T, Nisizawa T. Identification of human antigenic epitopes in an alanine-rich repeating region using sera from hu-PBL-SCID mice immunized with a surface protein antigen of Streptococcus mutans. Oral Microbiol Immunol 1996;5:343-349.
43. Carlsson RC, Martensson C, Kalliomaki S, Ohlin M, Borrebaeck CA. Human peripheral blood lymphocytes, transplanted into SCID mice constitute an in vivo culture system exhibiting several parameters found in a normal humoral immune response and are a source of immunocytes for the production of human monoclonal antibodies J Immunol 1992;148:1065-1071